Abstract: Anode assembly (100) comprising an anode (3) and an anode support (4) for the production of aluminum, characterized in that the anode assembly (100) comprises an electrical connecting element (1) to electrically connect the anode support (4) with the anode (3), and at least one thermally insulating element (6) arranged to reduce heat transfer between the anode (3) and the anode support (4) during the production of aluminum.

Abstract: Anode assembly (100) comprising an anode (3) and an anode support (4) for the production of aluminium, characterized in that the anode assembly (100) comprises an electrical connecting element (1) to electrically connect the anode support (4) with the anode (3), and at least one thermally insulating element (6) arranged to reduct heat transfer between the anode (3) and the anode support (4) during the production of aluminium.

Abstract: Compounds of Formula (I) wherein n, m, R1, R2, R3, R4, R5 and R6 are defined herein, are useful for the treatment of cytomegalovirus disease and/or infection.

Abstract: Compounds of Formula (I) wherein n, R1, R1A, R2, R3, Y and Z are defined herein, are useful for the treatment of cytomegalovirus disease and/or infection.

Abstract: Compounds of Formula (I) wherein n, A, R1, R2, R3 and R5 are defined herein, are useful for the treatment of cytomegalovirus disease and/or infection.

Abstract: Compounds of Formula (I) wherein n, R1, R1A, R2, R3, Y and Z are defined herein, are useful for the treatment of cytomegalovirus disease and/or infection.

Abstract: Compounds of Formula (I) wherein n, m, R1, R2, R3, R4, R5 and R6 are defined herein, are useful for the treatment of cytomegalovirus disease and/or infection.

Abstract: The present invention relates to a method for measuring levels of class VI isoprostane, an early predictive marker of pre-eclampsia (PE). The present invention also relates to an assay and diagnostic kit for performing the method of predicting PE by measuring the level of this marker and optionally establishing a ratio over other markers such as polyunstaturated fatty acids (PUFA) or beta-carotene. In particular, the method determines the level a class VI isoprostane in a blood sample from a pregnant woman prior to the appearance of symptoms of PE.

Abstract: Compounds of Formula (I) wherein n, A, R1, R2, R3 and R5 are defined herein, are useful for the treatment of cytomegalovirus disease and/or infection.

Abstract: Compounds of formula I: wherein R4, R6 and R7 are defined herein, are useful as inhibitors of HIV replication.

Abstract: Compounds of formula I: wherein a, R1, R2, R3, R4, R5 and R6 are defined herein, are useful as inhibitors of HIV replication.

Abstract: Compounds of formula I: wherein R4, R6 and R7 are defined herein, are useful as inhibitors of HIV replication.

Abstract: Compounds of formula I: wherein c, R2, R3, R4, R5, R6, R7 and R8 are defined herein, are useful as inhibitors of HIV replication.

Abstract: Compounds of formula I: wherein R4, R6 and R7 are defined herein, are useful as inhibitors of HIV replication.

Abstract: Compounds of formula I: wherein a, R1, R2, R3, R4, R5 and R6 are defined herein, are useful as inhibitors of HIV replication.

Abstract: Compounds of formula I: wherein c, R2, R3, R4, R5, R6, R7 and R8 are defined herein, are useful as inhibitors of HIV replication.

Abstract: Compounds of formula I: wherein R4, R6 and R7 are defined herein, are useful as inhibitors of HIV replication.

Abstract: Compounds of formula (I): wherein R1, R2, X, R3, D, and the dotted line b are as defined herein; or a pharmaceutically acceptable salt or ester thereof, are useful as inhibitors of the HCV NS3 protease.

Abstract: Compounds of formula I: wherein R1, R2, R2a, R3, R4 and R5 are defined herein, are useful as inhibitors of the HCV NS3 protease.

Abstract: A method is described for priming an in-line molten metal filtration unit having a porous ceramic or refractory filter mounted substantially horizontally in a filter box. This filter box has an inlet for molten metal and an outlet for molten metal, the outlet being a closeable outlet in an exit well connecting to the downstream side of the filter. The method of the invention comprises the steps of adding a molten metal to the filter box sufficient to entirely cover the upstream side of the filter with a depth of molten metal and temporarily sealing the outlet in the exit well. A steadily increasing vacuum is then applied to the closed exit well at a rate between 0.1 and 10 kPa per second by withdrawing a stream of air from the exit well by means of a fan or air venturi until molten metal begins to flow through the filter. At that point the vacuum is quickly released and the molten metal outlet is opened.